ATE272639T1 - Imidazopyrimidin-derivate und triazolopyrimidin- derivate - Google Patents

Imidazopyrimidin-derivate und triazolopyrimidin- derivate

Info

Publication number: ATE272639T1
Authority: AT; Austria
Prior art keywords: derivatives; imidazopyrimidine; triazolopyrimidine; triazolopyrimidine derivatives; imidazopyrimidine derivatives
Prior art date: 2000-04-28

Application number

AT01936242T

Other languages

English (en)

Inventor

Takeshi Yura

Arnel B Concepcion

Gyoonhee Han

Makiko Hiraoka

Hiroko Katsumata

Norihiro Kawamura

Toshio Kokubo

Hiroshi Komura

Yingfu Li

Timothy B Lowinger

Muneto Mogi

Noriyuki Yamamoto

Nagahiro Yoshida

Ming Wang

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-28

Filing date

2001-04-17

Publication date

2004-08-15

2001-04-17 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2004-08-15 Application granted granted Critical

2004-08-15 Publication of ATE272639T1 publication Critical patent/ATE272639T1/de

Links

150000005237 imidazopyrimidines Chemical class 0.000 title 1
YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

AT01936242T 2000-04-28 2001-04-17 Imidazopyrimidin-derivate und triazolopyrimidin- derivate ATE272639T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000128870A JP2001302667A (ja)	2000-04-28	2000-04-28	イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
PCT/EP2001/004357 WO2001083485A1 (en)	2000-04-28	2001-04-17	Imidazopyrimidine derivatives and triazolopyrimidine derivatives

Publications (1)

Publication Number	Publication Date
ATE272639T1 true ATE272639T1 (de)	2004-08-15

Family

ID=18638240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01936242T ATE272639T1 (de)	2000-04-28	2001-04-17	Imidazopyrimidin-derivate und triazolopyrimidin- derivate

Country Status (37)

Country	Link
US (1)	US6911443B2 (de)
EP (1)	EP1278750B1 (de)
JP (2)	JP2001302667A (de)
KR (1)	KR20030009456A (de)
CN (1)	CN1263756C (de)
AR (1)	AR033367A1 (de)
AT (1)	ATE272639T1 (de)
AU (1)	AU783043B2 (de)
BG (1)	BG107166A (de)
BR (1)	BR0110404A (de)
CA (1)	CA2407531A1 (de)
CZ (1)	CZ20023551A3 (de)
DE (1)	DE60104671T2 (de)
DK (1)	DK1278750T3 (de)
DO (1)	DOP2001000151A (de)
EE (1)	EE200200606A (de)
ES (1)	ES2225546T3 (de)
HR (1)	HRP20020943A2 (de)
HU (1)	HUP0300846A2 (de)
IL (1)	IL151919A0 (de)
MA (1)	MA25746A1 (de)
MX (1)	MXPA02010579A (de)
MY (1)	MY141578A (de)
NO (1)	NO20025154D0 (de)
NZ (2)	NZ526221A (de)
PE (1)	PE20011287A1 (de)
PL (1)	PL358106A1 (de)
PT (1)	PT1278750E (de)
RU (1)	RU2306313C2 (de)
SI (1)	SI1278750T1 (de)
SK (1)	SK15332002A3 (de)
SV (1)	SV2001000416A (de)
TR (1)	TR200402300T4 (de)
TW (1)	TWI222974B (de)
UA (1)	UA72615C2 (de)
WO (1)	WO2001083485A1 (de)
ZA (1)	ZA200207676B (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002081443A1 (en)	2001-04-09	2002-10-17	Chiron Corporation	Novel guanidino compounds
DE60303238T2 (de)	2003-04-25	2006-09-14	Actimis Pharmaceuticals, Inc., La Jolla	Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
US20070129383A1 (en) *	2003-10-17	2007-06-07	Hiroshi Kuramochi	Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof
US7572914B2 (en)	2003-12-19	2009-08-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
DK1718649T3 (da)	2004-01-31	2009-08-24	Actimis Pharmaceuticals Inc	Imidazo[1,2-c]pyrimidinyleddikesyrederivater
JP2008504294A (ja) *	2004-06-25	2008-02-14	アムジエン・インコーポレーテツド	サイトカイン介在疾患および他の疾患の治療において有用な縮合トリアゾールおよびインダゾール
WO2006023931A2 (en)	2004-08-18	2006-03-02	Takeda San Diego, Inc.	Kinase inhibitors
WO2006023866A2 (en)	2004-08-23	2006-03-02	Wyeth	Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
MX2007002178A (es)	2004-08-23	2007-04-02	Wyeth Corp	Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
WO2006023864A1 (en)	2004-08-23	2006-03-02	Wyeth	Pyrrolo-naphthyl acids as pai-1 inhibitors
EP1812439B2 (de) *	2004-10-15	2017-12-06	Takeda Pharmaceutical Company Limited	Kinaseinhibitoren
BRPI0607062A2 (pt)	2005-02-28	2009-08-04	Japan Tobacco Inc	composto de aminopiridina com atividade inibidora de syk, composição farmacêutica e agente terapêutico compreendendo os mesmos
US7442700B2 (en)	2005-07-01	2008-10-28	Bristol-Myers Squibb Company	Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
US8119655B2 (en) *	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
JP2009511527A (ja) *	2005-10-13	2009-03-19	グラクソグループリミテッド	Ｓｙｋ阻害物質としてのピロロピリミジン誘導体
CL2007002617A1 (es) *	2006-09-11	2008-05-16	Sanofi Aventis	Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
JP2010505962A (ja)	2006-10-09	2010-02-25	武田薬品工業株式会社	キナーゼ阻害剤
EP2223925A1 (de) *	2006-10-09	2010-09-01	Takeda Pharmaceutical Company Limited	Kinase-Inhibitoren
GEP20125658B (en) *	2006-11-22	2012-10-10	Incyte Corp	Imidazotriazines and imidazo pyrimidines as kinase inhibitors
CN101611035A (zh)	2006-12-28	2009-12-23	大正制药株式会社	吡唑并嘧啶化合物
DE102007012645A1 (de) *	2007-03-16	2008-09-18	Bayer Healthcare Ag	Substituierte Imidazo- und Triazolopyrimidine
EP2205569B1 (de)	2007-09-25	2012-02-29	Actimis Pharmaceuticals, Inc.,	Alkylthiopyrimidine als crth2-antagonisten
KR20100061746A (ko)	2007-09-25	2010-06-08	액티미스 파마수티컬스 인코포레이티드	Ｃｒｔｈ２ 길항제로서의 ２－ｓ－벤질 치환된 피리미딘
DE102008023801A1 (de)	2008-05-15	2009-11-19	Bayer Schering Pharma Aktiengesellschaft	Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine
PE20120121A1 (es)	2008-12-08	2012-02-20	Gilead Connecticut Inc	Derivados de imidazopirazina como inhibidores de syk
EA020461B1 (ru)	2008-12-08	2014-11-28	Джилид Коннектикут, Инк.	ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk
CA2765534C (en)	2009-06-15	2018-09-18	Rigel Pharmaceuticals, Inc.	Small molecule inhibitors of spleen tyrosine kinase (syk)
EP2516434B1 (de)	2009-12-23	2015-05-27	Takeda Pharmaceutical Company Limited	Geschmolzene heteroaromatische pyrrolidinone als syk-hemmer
JP5938352B2 (ja)	2010-03-11	2016-06-22	ギリアードコネチカット，インコーポレイテッド	イミダゾピリジンｓｙｋ阻害剤
KR20130094710A (ko) *	2010-04-14	2013-08-26	어레이 바이오파마 인크.	Ｊａｋ 키나아제의 억제제로서 5,7-치환된-이미다조［1,2-ｃ］피리미딘
AU2012253885A1 (en)	2011-05-10	2013-10-31	Merck Sharp & Dohme Corp.	Aminopyrimidines as Syk inhibitors
WO2012154518A1 (en)	2011-05-10	2012-11-15	Merck Sharp & Dohme Corp.	Bipyridylaminopyridines as syk inhibitors
CA2834062A1 (en)	2011-05-10	2012-11-15	Merck Sharp & Dohme Corp.	Pyridyl aminopyridines as syk inhibitors
WO2012167423A1 (en)	2011-06-08	2012-12-13	Hutchison Medipharma Limited	Substituted pyridopyrazines as novel syk inhibitors
WO2012177714A1 (en)	2011-06-22	2012-12-27	Takeda Pharmaceutical Company Limited	Substituted 6-aza-isoindolin-1-one derivatives
JP6105594B2 (ja)	2011-09-30	2017-03-29	エンドゥファーマシューティカルズ，インコーポレイティド	癌処置用ｃｙｐ１７阻害剤としてのイミダゾール誘導体
WO2013052391A1 (en)	2011-10-05	2013-04-11	Merck Sharp & Dohme Corp.	PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
US8987456B2 (en)	2011-10-05	2015-03-24	Merck Sharp & Dohme Corp.	3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
EP2763976B1 (de)	2011-10-05	2016-05-18	Merck Sharp & Dohme Corp.	2-pyridyl-carboxamid-haltige milztyrosinkinase-hemmer
SG11201401342VA (en) *	2011-10-12	2014-09-26	Array Biopharma Inc	5,7-substituted-imidazo[1,2-c]pyrimidines
DK2799431T3 (en) *	2011-12-28	2018-03-26	Fujifilm Corp	Hitherto unknown nicotinamide derivatives or salts thereof
WO2013192125A1 (en)	2012-06-20	2013-12-27	Merck Sharp & Dohme Corp.	Pyrazolyl derivatives as syk inhibitors
EP2863913B1 (de)	2012-06-20	2018-09-12	Merck Sharp & Dohme Corp.	Imidazolylanaloga als syk-hemmer
WO2013192088A1 (en)	2012-06-22	2013-12-27	Merck Sharp & Dohme Corp.	SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
US9376418B2 (en)	2012-06-22	2016-06-28	Merck Sharp & Dohme Corp.	Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
EP2884982B1 (de)	2012-08-20	2017-09-20	Merck Sharp & Dohme Corp.	Substituierte phenyl-milz-tyrosinkinaseinhibitoren
WO2014048065A1 (en)	2012-09-28	2014-04-03	Merck Sharp & Dohme Corp.	Triazolyl derivatives as syk inhibitors
EP2931281B1 (de)	2012-12-12	2018-01-17	Merck Sharp & Dohme Corp.	Aminopyridinhaltige milz-tyrosinkinase-hemmer
EP2934525B1 (de)	2012-12-21	2019-05-08	Merck Sharp & Dohme Corp.	Thiazolsubstituierte aminopyridine als milztyrosinkinasehemmer
EP2988744A4 (de)	2013-04-26	2016-11-02	Merck Sharp & Dohme	Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
WO2014176216A1 (en)	2013-04-26	2014-10-30	Merck Sharp & Dohme Corp.	Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
PL3027171T3 (pl)	2013-07-30	2020-08-24	Gilead Connecticut, Inc.	Formulacja inhibitorów syk
EA029281B1 (ru)	2013-07-30	2018-03-30	Джилид Коннектикут, Инк.	Полиморф ингибиторов syk
AU2014360537B2 (en)	2013-12-04	2017-09-07	Gilead Sciences, Inc.	Methods for treating cancers
EP3083559B1 (de)	2013-12-20	2021-03-10	Merck Sharp & Dohme Corp.	Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
US9670196B2 (en)	2013-12-20	2017-06-06	Merck Sharp & Dohme Corp.	Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
WO2015094997A1 (en)	2013-12-20	2015-06-25	Merck Sharp & Dohme Corp.	Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
TWI662037B (zh)	2013-12-23	2019-06-11	美商基利科學股份有限公司	脾酪胺酸激酶抑制劑
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
WO2015138273A1 (en)	2014-03-13	2015-09-17	Merck Sharp & Dohme Corp.	2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
ES2738416T3 (es) *	2014-03-19	2020-01-22	Boehringer Ingelheim Int	Inhibidores heteroarílicos de SYK
CN106687139A (zh)	2014-07-14	2017-05-17	吉利德科学公司	用于治疗癌症的组合
ES2745284T3 (es)	2015-09-11	2020-02-28	Boehringer Ingelheim Int	Heteroarilos sustituidos con pirazolilo y su uso como medicamentos
KR20220070056A (ko)	2017-08-25	2022-05-27	길리애드 사이언시즈, 인코포레이티드	Syk 억제제의 다형체
AU2018350683A1 (en)	2017-10-19	2020-04-02	Bayer Animal Health Gmbh	Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
KR102775718B1 (ko)	2017-11-14	2025-03-06	칠드런'즈 메디컬 센터 코포레이션	인간 면역 반응을 조정하기 위한 이미다조피리미딘의 용도
KR102740831B1 (ko)	2017-11-14	2024-12-11	칠드런'즈 메디컬 센터 코포레이션	신규 이미다조피리미딘 화합물 및 그의 용도
JP7370079B2 (ja) *	2018-06-06	2023-10-27	国立大学法人北海道大学	グリオーマの処置剤および医薬組成物
WO2019235572A1 (ja) *	2018-06-06	2019-12-12	富士フイルム株式会社	固形がんの処置剤および医薬組成物
WO2019235571A1 (ja) *	2018-06-06	2019-12-12	富士フイルム株式会社	血液がんの処置剤および医薬組成物
EP3873608A1 (de)	2018-10-31	2021-09-08	Gilead Sciences, Inc.	Substituierte 6-azabenzimidazolverbindungen mit hpk1-hemmender aktivität
EP4371987B9 (de)	2018-10-31	2025-11-26	Gilead Sciences, Inc.	Substituierte 6-azabenzimidazolverbindungen als hpk1-inhibitoren
AU2020225455A1 (en)	2019-02-22	2021-09-09	Kronos Bio, Inc.	Solid forms of condensed pyrazines as Syk inhibitors
CA3129665A1 (en)	2019-03-21	2020-09-24	Onxeo	A dbait molecule in combination with kinase inhibitor for the treatment of cancer
US11453681B2 (en)	2019-05-23	2022-09-27	Gilead Sciences, Inc.	Substituted eneoxindoles and uses thereof
KR20220098759A (ko)	2019-11-08	2022-07-12	인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔)	키나제 억제제에 대해 내성을 획득한 암의 치료 방법
WO2021148581A1 (en)	2020-01-22	2021-07-29	Onxeo	Novel dbait molecule and its use
WO2021173476A1 (en) *	2020-02-24	2021-09-02	The Trustees Of Columbia University In The City Of New York	Compounds, pharmaceutical formulations, and methods for treatment of cancer
EP4244223A1 (de) *	2020-11-13	2023-09-20	Biogen MA Inc.	Pyrazolo[1,5-a pyrazinderivate als btk inhibitoren
EP4430048A1 (de) *	2021-11-12	2024-09-18	Biogen MA Inc.	Btk-inhibitoren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4483987A (en) *	1983-06-20	1984-11-20	G. D. Searle & Co.	8-Substituted 7-phenyl-1,2,4-triazolo[2,3-c]pyrimidines-5-amines and amides
FR2549834B1 (fr) *	1983-07-25	1985-10-18	Sanofi Sa	Derives de triazolo-pyrimidine, leur procede de preparation et leur application therapeutique en tant que tonicardiaques
AU744939B2 (en)	1997-09-26	2002-03-07	Merck & Co., Inc.	Novel angiogenesis inhibitors
ATE401312T1 (de)	1997-12-15	2008-08-15	Astellas Pharma Inc	Pyrimidin-5-carboxamid-derivate
US6673564B2 (en) *	1999-10-18	2004-01-06	Millennium Pharmaceuticals, Inc.	Methods for using 22045, a human cyclic nucleotide phosphodiesterase

2000
- 2000-04-28 JP JP2000128870A patent/JP2001302667A/ja active Pending
2001
- 2001-04-17 SK SK1533-2002A patent/SK15332002A3/sk unknown
- 2001-04-17 KR KR1020027014441A patent/KR20030009456A/ko not_active Ceased
- 2001-04-17 CN CNB018117201A patent/CN1263756C/zh not_active Expired - Fee Related
- 2001-04-17 TR TR2004/02300T patent/TR200402300T4/xx unknown
- 2001-04-17 WO PCT/EP2001/004357 patent/WO2001083485A1/en not_active Ceased
- 2001-04-17 EE EEP200200606A patent/EE200200606A/xx unknown
- 2001-04-17 DE DE60104671T patent/DE60104671T2/de not_active Expired - Fee Related
- 2001-04-17 HR HR20020943A patent/HRP20020943A2/hr not_active Application Discontinuation
- 2001-04-17 AU AU62204/01A patent/AU783043B2/en not_active Ceased
- 2001-04-17 PL PL01358106A patent/PL358106A1/xx not_active Application Discontinuation
- 2001-04-17 CZ CZ20023551A patent/CZ20023551A3/cs unknown
- 2001-04-17 EP EP01936242A patent/EP1278750B1/de not_active Expired - Lifetime
- 2001-04-17 AT AT01936242T patent/ATE272639T1/de not_active IP Right Cessation
- 2001-04-17 IL IL15191901A patent/IL151919A0/xx unknown
- 2001-04-17 BR BR0110404-7A patent/BR0110404A/pt not_active IP Right Cessation
- 2001-04-17 DK DK01936242T patent/DK1278750T3/da active
- 2001-04-17 NZ NZ526221A patent/NZ526221A/en unknown
- 2001-04-17 PT PT01936242T patent/PT1278750E/pt unknown
- 2001-04-17 JP JP2002500795A patent/JP2003535067A/ja active Pending
- 2001-04-17 UA UA2002119418A patent/UA72615C2/uk unknown
- 2001-04-17 HU HU0300846A patent/HUP0300846A2/hu unknown
- 2001-04-17 ES ES01936242T patent/ES2225546T3/es not_active Expired - Lifetime
- 2001-04-17 US US10/258,628 patent/US6911443B2/en not_active Expired - Fee Related
- 2001-04-17 MX MXPA02010579A patent/MXPA02010579A/es active IP Right Grant
- 2001-04-17 SI SI200130178T patent/SI1278750T1/xx unknown
- 2001-04-17 NZ NZ522241A patent/NZ522241A/en unknown
- 2001-04-17 RU RU2002132193/04A patent/RU2306313C2/ru not_active IP Right Cessation
- 2001-04-17 CA CA002407531A patent/CA2407531A1/en not_active Abandoned
- 2001-04-25 DO DO2001000151A patent/DOP2001000151A/es unknown
- 2001-04-26 MY MYPI20011983A patent/MY141578A/en unknown
- 2001-04-27 TW TW090110055A patent/TWI222974B/zh not_active IP Right Cessation
- 2001-04-27 AR ARP010102006A patent/AR033367A1/es not_active Application Discontinuation
- 2001-04-27 PE PE2001000382A patent/PE20011287A1/es not_active Application Discontinuation
- 2001-04-27 SV SV2001000416A patent/SV2001000416A/es not_active Application Discontinuation
2002
- 2002-09-25 ZA ZA200207676A patent/ZA200207676B/xx unknown
- 2002-10-03 BG BG107166A patent/BG107166A/bg unknown
- 2002-10-25 NO NO20025154A patent/NO20025154D0/no not_active Application Discontinuation
- 2002-10-28 MA MA26885A patent/MA25746A1/fr unknown

Also Published As

Publication number	Publication date
TWI222974B (en)	2004-11-01
PL358106A1 (en)	2004-08-09
DOP2001000151A (es)	2002-05-15
NZ526221A (en)	2005-01-28
NO20025154L (no)	2002-10-25
CA2407531A1 (en)	2001-10-25
WO2001083485A1 (en)	2001-11-08
EP1278750A1 (de)	2003-01-29
PT1278750E (pt)	2004-11-30
MXPA02010579A (es)	2003-05-14
CZ20023551A3 (cs)	2003-01-15
RU2306313C2 (ru)	2007-09-20
EE200200606A (et)	2004-04-15
CN1263756C (zh)	2006-07-12
BR0110404A (pt)	2003-02-11
US20040054179A1 (en)	2004-03-18
DK1278750T3 (da)	2004-11-22
HRP20020943A2 (en)	2005-02-28
NZ522241A (en)	2004-04-30
ZA200207676B (en)	2003-09-25
DE60104671T2 (de)	2005-12-29
KR20030009456A (ko)	2003-01-29
ES2225546T3 (es)	2005-03-16
MY141578A (en)	2010-05-14
TR200402300T4 (tr)	2004-12-21
JP2001302667A (ja)	2001-10-31
BG107166A (bg)	2003-06-30
DE60104671D1 (de)	2004-09-09
SV2001000416A (es)	2001-07-03
UA72615C2 (en)	2005-03-15
AU783043B2 (en)	2005-09-22
AR033367A1 (es)	2003-12-17
HK1058362A1 (en)	2004-05-14
CN1439009A (zh)	2003-08-27
AU6220401A (en)	2001-11-12
SI1278750T1 (en)	2005-02-28
HUP0300846A2 (hu)	2003-08-28
PE20011287A1 (es)	2002-02-27
JP2003535067A (ja)	2003-11-25
MA25746A1 (fr)	2003-04-01
IL151919A0 (en)	2003-04-10
EP1278750B1 (de)	2004-08-04
NO20025154D0 (no)	2002-10-25
SK15332002A3 (sk)	2003-06-03
US6911443B2 (en)	2005-06-28

Legal Events

Date

Code

Title

Description

2005-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1278750

Country of ref document: EP

2010-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60104671D1 (de)	2004-09-09	Imidazopyrimidin-derivate und triazolopyrimidin-derivate
AR028622A1 (es)	2003-05-14	Derivados de tropano utiles en terapia
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
DE60120268D1 (de)	2006-07-20	Fahrrad und Fahrradfaltverfahren
MA26612A1 (fr)	2004-12-20	Pyrazolopyrimidines et pyrazolotriazines
ATE306318T1 (de)	2005-10-15	Entschwefelung und hierfür geeignetes sorbens
DE60026297D1 (de)	2006-04-27	Pyrrolotriazin kinasehemmer
DE60027759D1 (de)	2006-06-08	Absorbierender artikel
DE60005810D1 (de)	2003-11-13	Fussstütze und möbelstück
DE60020536D1 (de)	2005-07-07	Absorbierender artikel
DE60039814D1 (de)	2008-09-25	Absorbierender Artikel
DE60018133D1 (de)	2005-03-24	Absorbierender Artikel
FR2801195B3 (fr)	2001-11-02	Article absorbant
DE60030038D1 (de)	2006-09-28	Absorbierender Artikel
DE60038972D1 (de)	2008-07-03	Absorbierender artikel
DE60044183D1 (de)	2010-05-27	Absorbierender artikel
DE60020737D1 (de)	2005-07-14	Sic-einkristall und herstellungsverfahren dafür
FR2809684B1 (fr)	2002-10-11	Accoudoir escamotable
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
ATE242051T1 (de)	2003-06-15	Mykotoxin-adsorbens
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
NO20020873L (no)	2002-04-18	Omfestbar absorberende artikkel
DE60103909D1 (de)	2004-07-22	2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
DE50208341D1 (de)	2006-11-16	Triazolopyrimidine
NO20004072D0 (no)	2000-08-15	Absorberende artikkel